Preclinical Study of CDH3-Targeted 89 Zr/ 177 Lu Theranostics in Triple-Negative Breast Cancer
Year: 2026
Type: article
Abstract: Lu-11E10C11 dual-functional probe successfully achieved an integrated "diagnosis-therapy" strategy, offering a novel approach with translational potential for precision management of TNBC.
Source: Molecular Pharmaceutics
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7125546473
